Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles

Reza Dana, M.D.

Title
Institution
Department
Address
Phone
Fax
Profile Picture

Biography
1995
Fellowship (Ocular Immunology)
1996
Named Fellow of the Society of Heed Fellows (Special Recognition Award)
1996
Clinical Scientist Career Award
1999
Invited Participant
1999
William and Mary Greve Scholar (RPB Special Scholar Award)
2000
Second Decade Society (alumni honor)
2002
Achievment Award
2002
Kronfeld Memorial Lecturer
2002
Fry Memorial Lecturer
2003
Cogan Award
2003
Dohlman Lecturer
2004
Alta Lecturer and Visiting Professorship
2004
Keynote Speaker
2005
Physician Scientist Merit Award
2006
Service Recognition Award
2007
Certificate of Appreciation
2008
Alcon Research Institute Award
2009 - 2010
Lew R. Wasserman Merit Award
2011
David Easty Lecturer
2011
Joaquin Barraquer Lecturer
2012
Chancellor’s Award in Neuroscience and Ophthalmology
2012
Mentoring Award
2013
Gold Fellow
2013
Keynote Speaker
2013
Senior Scientific Investigator Award
2014
A. Clifford Barger Excellence in Mentoring Award
2014
Thygeson Lecturer

Overview
I am an ophthalmologist and immunologist whose principal research interest is determining the molecular and cellular regulation of corneal and ocular surface immunity. In particular, we focus on the role of cytokines and chemokines in induction of antigen-specific corneal immunology, recruitment and activation of ocular antigen-presenting cells, and the interface of lymphangiogenesis and corneal inflammation. The principal venue of my research activities is in my laboratory at the Schepens Eye Research Institute, but is complemented with extensive ‘clinic-to-lab’ and translational ‘lab-to-clinic’ research activities that are performed in conjunction with my academic clinical subspecialty practice at the Massachusetts Eye and Ear Infirmary (see further below for details).

To address the principal objectives of our research program, we optimized the orthotopic model of corneal transplantation in the mouse to determine specific mechanisms involved in: (i) antigen-presenting cell (APC) mobilization in the cornea, (ii) APC-blood and –lymph vessel interactions, (iii) APC mobilization from eye to lymphoid organs including regional draining lymph nodes, and (iv) APC sensitization of T cells in transplantation and autoimmunity. Our work has been instrumental in delineating the precise mechanisms by which pro-inflammatory cytokines work in concert to upregulate specific chemokines and cell adhesion molecules that mediate trans-endothelial migration of APCs from the intravascular compartment into the corneo-limbal matrix. We have shown that this process of APC mobilization into the corneal matrix can be effectively suppressed, with concomitant blunting in the activation of cornea-specific immunity, with topical blockade of relevant cytokines and chemokines. We subsequently showed that once mobilized, these antigen-laden APCs can migrate from the graft to regional lymph nodes to induce T helper-1 type immunity through an interleukin-12-dependent mechanism. This pathway which becomes activated in states of high inflammation is distinct from the normal (default) migration of “tolerogenic” ocular APC to the spleen where they can promote a specific form of immune unresponsiveness termed anterior chamber-associated immune deviation, explaining how the eye, an immune privileged organ, can also be susceptible to destructive immunity. We have also shown the T cell response generated differs considerably between transplants and in chronic autoimmunity (the latter as seen in dry eye disease).

Our work led to important novel and unexpected discoveries. My lab was the first to discover several distinct populations of uniformly MHC class II— highly immature APCs (including epithelial Langerhans cells and stromal CD11b+ myeloid CD11c+ dendritic cells) in the central cornea, breaking a longstanding dogma that the cornea was devoid of any antigen-presenting cell population. We also showed that these immature/precursor populations can mature to acquire high CD40, CD80, and MHC class II expression as they egress the eye through selective upregulation of specific receptors (e.g. CCR7) to prime naïve T cells under conditions of inflammation, including after corneal transplantation. We have also determined a novel role for the tyrosine kinase receptor vascular endothelial growth factor receptor-3 (VEGFR-3), which is known to be a growth factor for lymphatic (and to some extent budding blood vessel) endothelia. We have determined that this receptor is expressed by mature MHC class IIhi dendritic cells in the cornea, and mediates their chemotactic mobilization into lymphatics, thereby allowing their egress from the eye. Importantly, we showed that blockade of this pathway can suppress the trafficking of APC from the eye to regional lymph nodes and suppress the induction of delayed hypersensitivity to corneal transplants—a finding we published in Nature Medicine. We have also successfully demonstrated that disruption of the ‘eye-lymphatic axis’ pharmacologically can suppress generation of autoimmune dry eye disease.

Our work has also shed light onto one of the oldest mysteries in ophthalmic biology—namely, how the cornea maintains its avascular structure, and thereby allows for light to be focused on the retina with minimal interference. We have shown high constitutive and ectopic expression of VEGFR-3 by the corneal epithelium serves as a “sink” mechanism for VEGF-C/D, preventing their ligation of vascular endothelial VEGFR-2, and thereby functioning as a critical mechanism for maintaining corneal avascularity (PNAS). More recently, we have shown that IL-17 can promote lymphatic development through upregulation of VGEF-D (Blood).

Our work in corneal transplantation immunology permitted us since 2006 to launch a broad and productive program determining the immunopathogenesis of dry eye disease, a chronic autoimmune disease whose precise pathogenesis was barely understood even a few years earlier. We developed, and validated, a novel preclinical model for dry eye disease that did not rely on gene deletion or transgenic technology and used it in our basic research program to focus on the molecular mechanisms that mediate (i) selective growth of neolymphatics into dry eye corneas, (ii) induction of T helper-1 (Th1) and Th17 autoimmunity, (iii) development of Th17 cell resistance to Treg suppression, and (iv) the expression of autoreactive T cell homing chemokines on the ocular surface. These studies have been complemented with a number of ‘proof of concept’ therapeutic strategies in preclinical models of dry eye, such as antagonism of cytokines (IL-1, IL-17), prolymphangiogenic factors (VEGF-C/D, VEGFR-3), T cell homing chemokines (CCR5), and leukocyte recruitment mechanisms such as integrins (VLA-4). More recently, we have shown that development of chronic ocular surface/dry eye disease is linked to development of effector memory IL-17 secreting cells, whose function amplifies autoimmunity by suppressing regulatory T cells pathways.

These basic investigation efforts have been complemented with an active program in clinical and translational research. We created the Cornea Research department at the Mass Eye and Ear in 2007 and the Ocular Surface Imaging Center in 2009; these are staffed by several full-time staff, where a large number of investigator-initiated studies are performed. Studies have focused on novel strategies to manage high-risk corneal and stem cell transplants, pathological corneal angiogenesis, dry eye, and in vivo corneal immuno- and neuro-imaging. Our group has been one of the first to develop and clinically test biologic approaches in the management of corneal and ocular surface diseases. These studies have been facilitated by 8 successful FDA IND approvals received by our group since 2008. In all, the combined research efforts of the Dana group have led to over 200 peer-reviewed publications.

In addition to research, I have focused extensively on education, both clinical and research. This has included teaching of postdoctoral research fellows, clinical fellows and residents, and medical students and graduate students enrolled in various Harvard Medical School curricula—I have served as primary mentor to over 80 trainees from 29 countries. In addition to my considerable efforts to contribute to the investigation-based peer-reviewed literature, I served as one of the editors to the 14-volume American Academy of Ophthalmology Basic and Clinical Science Course (the principal educational tool of US and Canadian residents for Board certification), responsible for content in corneal inflammation and immunity. Finally, as a strong believer in the importance of clinical scientists in bridging the wide gap between basic science and clinical applications, I direct the Harvard-Vision Clinical Scientist Development Program funded by the NIH K12 mechanism- with the express intent of recruiting, training, and retaining the brightest young minds to Harvard to contribute to our research efforts. I have served as PI/Director for this program since its inception at Harvard Ophthalmology in 2004, and successfully received refunding in 2010 to continue the program. The $7M+ we have received for this program since 2004 has led to recruitment of numerous clinician-scientists to the Harvard Department of Ophthalmology.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01EY020889 (DANA, REZA) Sep 30, 2010 - Aug 31, 2019
    NIH/NEI
    Immunopathogenic mechanisms of dry eye disease
    Role: Principal Investigator
  2. K24EY019098 (DANA, REZA) Sep 15, 2008 - Aug 31, 2013
    NIH/NEI
    New Strategies for Modulation of Corneal and Ocular Surface Inflammation
    Role: Principal Investigator
  3. R21EY015738 (DANA, REZA) Apr 1, 2005 - Mar 31, 2007
    NIH/NEI
    Promoting Corneal Graft by Anti-Apoptotic Genes
    Role: Principal Investigator
  4. K12EY016335 (DANA, REZA) Sep 30, 2004 - Mar 31, 2021
    NIH/NEI
    Harvard-Vision Clinical Scientist Development Program
    Role: Principal Investigator
  5. R01EY012963 (DANA, REZA) Aug 1, 2000 - Jul 31, 2021
    NIH/NEI
    Mechanisms of Sensitization in High Risk Corneal Grafts
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Shao C, Chen Y, Nakao T, Amouzegar A, Yin J, Tahvildari M, Lužnik Z, Chauhan SK, Dana R. Local Delivery of Regulatory T Cells Promotes Corneal Allograft Survival. Transplantation. 2018 Sep 21. PMID: 30247445.
    View in: PubMed
  2. Satitpitakul V, Sun Z, Suri K, Amouzegar A, Katikireddy KR, Jurkunas UV, Kheirkhah A, Dana R. Vasoactive Intestinal Peptide Promotes Corneal Allograft Survival. Am J Pathol. 2018 Sep; 188(9):2016-2024. PMID: 30097165.
    View in: PubMed
  3. Tan X, Chen Y, Foulsham W, Amouzegar A, Inomata T, Liu Y, Chauhan SK, Dana R. The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease. Ocul Surf. 2018 Oct; 16(4):470-477. PMID: 30055331.
    View in: PubMed
  4. Kheirkhah A, Satitpitakul V, Syed ZA, Müller R, Goyal S, Tu EY, Dana R. Factors Influencing the Diagnostic Accuracy of Laser-Scanning In Vivo Confocal Microscopy for Acanthamoeba Keratitis. Cornea. 2018 Jul; 37(7):818-823. PMID: 29303889.
    View in: PubMed
  5. Amparo F, Shikari H, Saboo U, Dana R. Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD. Ocul Surf. 2018 Jul; 16(3):377-381. PMID: 29763694.
    View in: PubMed
  6. Hua J, Inomata T, Chen Y, Foulsham W, Stevenson W, Shiang T, Bluestone JA, Dana R. Pathological conversion of regulatory T cells is associated with loss of allotolerance. Sci Rep. 2018 May 04; 8(1):7059. PMID: 29728574.
    View in: PubMed
  7. Sullivan DA, Dana R, Sullivan RM, Krenzer KL, Sahin A, Arica B, Liu Y, Kam WR, Papas AS, Cermak JM. Meibomian Gland Dysfunction in Primary and Secondary Sjögren Syndrome. Ophthalmic Res. 2018; 59(4):193-205. PMID: 29627826.
    View in: PubMed
  8. Paschalis EI, Lei F, Zhou C, Kapoulea V, Thanos A, Dana R, Vavvas DG, Chodosh J, Dohlman CH. The Role of Microglia and Peripheral Monocytes in Retinal Damage after Corneal Chemical Injury. Am J Pathol. 2018 Jul; 188(7):1580-1596. PMID: 29630857.
    View in: PubMed
  9. Yin J, Kheirkhah A, Dohlman T, Saboo U, Dana R. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease. Am J Ophthalmol. 2018 Jun; 190:17-23. PMID: 29572107.
    View in: PubMed
  10. Dana R. A New Frontier in Curing Corneal Blindness. N Engl J Med. 2018 03 15; 378(11):1057-1058. PMID: 29539278.
    View in: PubMed
  11. Kheirkhah A, Coco G, Satitpitakul V, Dana R. Subtarsal Fibrosis Is Associated With Ocular Surface Epitheliopathy in Graft-Versus-Host Disease. Am J Ophthalmol. 2018 May; 189:102-110. PMID: 29505774.
    View in: PubMed
  12. Amparo F, Dana R. Web-based longitudinal remote assessment of dry eye symptoms. Ocul Surf. 2018 Apr; 16(2):249-253. PMID: 29409963.
    View in: PubMed
  13. Dohlman CH, Cade F, Regatieri CV, Zhou C, Lei F, Crnej A, Harissi-Dagher M, Robert MC, Papaliodis GN, Chen D, Aquavella JV, Akpek EK, Aldave AJ, Sippel KC, D'Amico DJ, Dohlman JG, Fagerholm P, Wang L, Shen LQ, González-Andrades M, Chodosh J, Kenyon KR, Foster CS, Pineda R, Melki S, Colby KA, Ciolino JB, Vavvas DG, Kinoshita S, Dana R, Paschalis EI. Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities. Cornea. 2018 Feb; 37(2):248-251. PMID: 29135604.
    View in: PubMed
  14. Eslani M, Putra I, Shen X, Hamouie J, Tadepalli A, Anwar KN, Kink JA, Ghassemi S, Agnihotri G, Reshetylo S, Mashaghi A, Dana R, Hematti P, Djalilian AR. Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function. Stem Cells. 2018 May; 36(5):775-784. PMID: 29341332.
    View in: PubMed
  15. Tahvildari M, Amouzegar A, Foulsham W, Dana R. Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation. Cell Mol Life Sci. 2018 May; 75(9):1509-1520. PMID: 29307015.
    View in: PubMed
  16. Inomata T, Hua J, Nakao T, Shiang T, Chiang H, Amouzegar A, Dana R. Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection. Cornea. 2018 Jan; 37(1):95-101. PMID: 29023237.
    View in: PubMed
  17. Foulsham W, Coco G, Amouzegar A, Chauhan SK, Dana R. When Clarity Is Crucial: Regulating Ocular Surface Immunity. Trends Immunol. 2018 Apr; 39(4):288-301. PMID: 29248310.
    View in: PubMed
  18. Marmalidou A, Kheirkhah A, Dana R. Conjunctivochalasis: a systematic review. Surv Ophthalmol. 2018 Jul - Aug; 63(4):554-564. PMID: 29128574.
    View in: PubMed
  19. Inomata T, Mashaghi A, Hong J, Nakao T, Dana R. Scaling and maintenance of corneal thickness during aging. PLoS One. 2017; 12(10):e0185694. PMID: 28985226.
    View in: PubMed
  20. Eslani M, Putra I, Shen X, Hamouie J, Afsharkhamseh N, Besharat S, Rosenblatt MI, Dana R, Hematti P, Djalilian AR. Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1. Invest Ophthalmol Vis Sci. 2017 10 01; 58(12):5507-5517. PMID: 29075761.
    View in: PubMed
  21. Hos D, Bukowiecki A, Horstmann J, Bock F, Bucher F, Heindl LM, Siebelmann S, Steven P, Dana R, Eming SA, Cursiefen C. Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency. Sci Rep. 2017 Aug 03; 7(1):7227. PMID: 28775329.
    View in: PubMed
  22. Kheirkhah A, Kempen J, Dana R. Reply. Am J Ophthalmol. 2017 Oct; 182:202-203. PMID: 28778570.
    View in: PubMed
  23. Kheirkhah A, Crnej A, Ren A, Mullins A, Satitpitakul V, Hamrah P, Schaumberg D, Dana R. Patients' Perceived Treatment Effectiveness in Dry Eye Disease. Cornea. 2017 Aug; 36(8):893-897. PMID: 28481835.
    View in: PubMed
  24. Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, Dong PN, Geerling G, Hida RY, Liu Y, Seo KY, Tauber J, Wakamatsu TH, Xu J, Wolffsohn JS, Craig JP. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017 07; 15(3):575-628. PMID: 28736343.
    View in: PubMed
  25. Amparo F, Yin J, Di Zazzo A, Abud T, Jurkunas UV, Hamrah P, Dana R. Evaluating Changes in Ocular Redness Using a Novel Automated Method. Transl Vis Sci Technol. 2017 Jul; 6(4):13. PMID: 28736686.
    View in: PubMed
  26. Kheirkhah A, Di Zazzo A, Satitpitakul V, Fernandez M, Magilavy D, Dana R. A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease. Cornea. 2017 Jul; 36(7):799-804. PMID: 28445193.
    View in: PubMed
  27. Lee HS, Amouzegar A, Dana R. Kinetics of Corneal Antigen Presenting Cells in Experimental Dry Eye Disease. BMJ Open Ophthalmol. 2017; 1(1):e000078. PMID: 29354712.
    View in: PubMed
  28. Chen Y, Chauhan SK, Shao C, Omoto M, Inomata T, Dana R. IFN-?-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity. J Immunol. 2017 08 01; 199(3):1163-1169. PMID: 28637904.
    View in: PubMed
  29. Foulsham W, Marmalidou A, Amouzegar A, Coco G, Chen Y, Dana R. Review: The function of regulatory T cells at the ocular surface. Ocul Surf. 2017 10; 15(4):652-659. PMID: 28576753.
    View in: PubMed
  30. Satitpitakul V, Kheirkhah A, Crnej A, Hamrah P, Dana R. Determinants of Ocular Pain Severity in Patients With Dry Eye Disease. Am J Ophthalmol. 2017 Jul; 179:198-204. PMID: 28528121.
    View in: PubMed
  31. Amparo F, Wang H, Yin J, Marmalidou A, Dana R. Evaluating Corneal Fluorescein Staining Using a Novel Automated Method. Invest Ophthalmol Vis Sci. 2017 05 01; 58(6):BIO168-BIO173. PMID: 28693042.
    View in: PubMed
  32. Kheirkhah A, Syed ZA, Satitpitakul V, Goyal S, Müller R, Tu EY, Dana R. Sensitivity and Specificity of Laser-Scanning In Vivo Confocal Microscopy for Filamentous Fungal Keratitis: Role of Observer Experience. Am J Ophthalmol. 2017 Jul; 179:81-89. PMID: 28445703.
    View in: PubMed
  33. Tahvildari M, Emami-Naeini P, Omoto M, Mashaghi A, Chauhan SK, Dana R. Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation. Sci Rep. 2017 04 20; 7(1):971. PMID: 28428556.
    View in: PubMed
  34. Paschalis EI, Zhou C, Lei F, Scott N, Kapoulea V, Robert MC, Vavvas D, Dana R, Chodosh J, Dohlman CH. Mechanisms of Retinal Damage after Ocular Alkali Burns. Am J Pathol. 2017 Jun; 187(6):1327-1342. PMID: 28412300.
    View in: PubMed
  35. Inomata T, Mashaghi A, Di Zazzo A, Lee SM, Chiang H, Dana R. Kinetics of Angiogenic Responses in Corneal Transplantation. Cornea. 2017 Apr; 36(4):491-496. PMID: 28060028.
    View in: PubMed
  36. Di Zazzo A, Tahvildari M, Subbarayal B, Yin J, Dohlman TH, Inomata T, Mashaghi A, Chauhan SK, Dana R. Proangiogenic Function of T Cells in Corneal Transplantation. Transplantation. 2017 04; 101(4):778-785. PMID: 27490416.
    View in: PubMed
  37. Aggarwal S, Yamaguchi T, Dana R, Hamrah P. Exophiala phaeomuriformis Fungal Keratitis: Case Report and In Vivo Confocal Microscopy Findings. Eye Contact Lens. 2017 Mar; 43(2):e4-e6. PMID: 26513718.
    View in: PubMed
  38. Kheirkhah A, Satitpitakul V, Hamrah P, Dana R. Patients With Dry Eye Disease and Low Subbasal Nerve Density Are at High Risk for Accelerated Corneal Endothelial Cell Loss. Cornea. 2017 Feb; 36(2):196-201. PMID: 28060067.
    View in: PubMed
  39. Dohlman TH, Ding J, Dana R, Chauhan SK. T Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration. Invest Ophthalmol Vis Sci. 2017 02 01; 58(2):1330-1336. PMID: 28241321.
    View in: PubMed
  40. Arafat SN, Robert MC, Abud T, Spurr-Michaud S, Amparo F, Dohlman CH, Dana R, Gipson IK. Elevated Neutrophil Elastase in Tears of Ocular Graft-Versus-Host Disease Patients. Am J Ophthalmol. 2017 Apr; 176:46-52. PMID: 28073648.
    View in: PubMed
  41. Abud TB, Di Zazzo A, Kheirkhah A, Dana R. Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation. J Ophthalmic Vis Res. 2017 Jan-Mar; 12(1):81-92. PMID: 28299010.
    View in: PubMed
  42. Syed ZA, Dana R. Novel Treatments for Corneal Angiogenesis. Int Ophthalmol Clin. 2017; 57(4):31-38. PMID: 28885245.
    View in: PubMed
  43. Inomata T, Hua J, Di Zazzo A, Dana R. Impaired Function of Peripherally Induced Regulatory T Cells in Hosts at High Risk of Graft Rejection. Sci Rep. 2016 12 23; 6:39924. PMID: 28008995.
    View in: PubMed
  44. Di Zazzo A, Kheirkhah A, Abud TB, Goyal S, Dana R. Management of high-risk corneal transplantation. Surv Ophthalmol. 2017 Nov - Dec; 62(6):816-827. PMID: 28012874.
    View in: PubMed
  45. Di Zazzo A, Tahvildari M, Florakis GJ, Dana R. Ocular Manifestations of Inherited Phospholipase-C?2-Associated Antibody Deficiency and Immune Dysregulation. Cornea. 2016 Dec; 35(12):1656-1657. PMID: 27442322.
    View in: PubMed
  46. Chen Y, Chauhan SK, Tan X, Dana R. Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity. J Autoimmun. 2017 Feb; 77:96-103. PMID: 27899224.
    View in: PubMed
  47. Hattori T, Takahashi H, Dana R. Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells. Cornea. 2016 Nov; 35 Suppl 1:S49-S54. PMID: 27631349.
    View in: PubMed
  48. Hong J, Yang Y, Cursiefen C, Mashaghi A, Wu D, Liu Z, Sun X, Dana R, Xu J. Optimising keratoplasty for Peters' anomaly in infants using spectral-domain optical coherence tomography. Br J Ophthalmol. 2017 06; 101(6):820-827. PMID: 27660330.
    View in: PubMed
  49. Subbarayal B, Chauhan SK, Di Zazzo A, Dana R. IL-17 Augments B Cell Activation in Ocular Surface Autoimmunity. J Immunol. 2016 11 01; 197(9):3464-3470. PMID: 27655846.
    View in: PubMed
  50. Kheirkhah A, Qazi Y, Arnoldner MA, Suri K, Dana R. In Vivo Confocal Microscopy in Dry Eye Disease Associated With Chronic Graft-Versus-Host Disease. Invest Ophthalmol Vis Sci. 2016 Sep 01; 57(11):4686-91. PMID: 27607414.
    View in: PubMed
  51. Crnej A, Kheirkhah A, Ren A, Mullins A, Lavric A, Suri K, Hamrah P, Dana R. Patients' Perspectives on Their Dry Eye Disease. Ocul Surf. 2016 10; 14(4):440-446. PMID: 27395775.
    View in: PubMed
  52. Mashaghi A, Hong J, Chauhan SK, Dana R. Ageing and ocular surface immunity. Br J Ophthalmol. 2017 Jan; 101(1):1-5. PMID: 27378485.
    View in: PubMed
  53. Campbell AA, Jakobiec FA, Rashid A, Dana R, Yoon MK. Bilateral Sequential Dacryocystitis in a Patient With Graft-Versus-Host Disease. Ophthalmic Plast Reconstr Surg. 2016 Jul-Aug; 32(4):e89-92. PMID: 25192327.
    View in: PubMed
  54. Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R. Neuropeptide substance P and the immune response. Cell Mol Life Sci. 2016 11; 73(22):4249-4264. PMID: 27314883.
    View in: PubMed
  55. Amouzegar A, Chauhan SK, Dana R. Alloimmunity and Tolerance in Corneal Transplantation. J Immunol. 2016 05 15; 196(10):3983-91. PMID: 27183635; PMCID: PMC4874505 [Available on 05/15/17].
  56. Ferrari G, Nallasamy N, Downs H, Dana R, Oaklander AL. Corrigendum to "Corneal innervation as a window to peripheral neuropathies" [Exp. Eye Res. 113 (2013) 148-150]. Exp Eye Res. 2016 04; 145:473. PMID: 27107348.
    View in: PubMed
  57. Qazi Y, Hurwitz S, Khan S, Jurkunas UV, Dana R, Hamrah P. Validity and Reliability of a Novel Ocular Pain Assessment Survey (OPAS) in Quantifying and Monitoring Corneal and Ocular Surface Pain. Ophthalmology. 2016 07; 123(7):1458-68. PMID: 27089999.
    View in: PubMed
  58. Abud TB, Amparo F, Saboo US, Di Zazzo A, Dohlman TH, Ciolino JB, Hamrah P, Dana R. A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease. Ophthalmology. 2016 07; 123(7):1449-57. PMID: 27086024; PMCID: PMC4921308 [Available on 07/01/17].
  59. Dohlman TH, Di Zazzo A, Omoto M, Hua J, Ding J, Hamrah P, Chauhan SK, Dana R. E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation. Transplantation. 2016 Apr; 100(4):772-80. PMID: 26910325; PMCID: PMC4801688 [Available on 04/01/17].
  60. Crnej A, Omoto M, Dohlman TH, Gonzalez-Andrades M, Paschalis EI, Cruzat A, Vu TH, Doorenbos M, Chen DF, Dohlman CH, Dana R. Effect of Penetrating Keratoplasty and Keratoprosthesis Implantation on the Posterior Segment of the Eye. Invest Ophthalmol Vis Sci. 2016 Apr; 57(4):1643-8. PMID: 27054516; PMCID: PMC4829084 [Available on 10/01/16].
  61. Robert MC, Crnej A, Shen LQ, Papaliodis GN, Dana R, Foster CS, Chodosh J, Dohlman CH. Infliximab after Boston Keratoprosthesis in Stevens-Johnson Syndrome: An Update. Ocul Immunol Inflamm. 2017 Jun; 25(3):413-417. PMID: 27015032.
    View in: PubMed
  62. Saboo US, Amparo F, Shikari H, Dana R. Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease. Graefes Arch Clin Exp Ophthalmol. 2016 May; 254(5):923-8. PMID: 26968719; PMCID: PMC4842331 [Available on 05/01/17].
  63. Hua J, Stevenson W, Dohlman TH, Inomata T, Tahvildari M, Calcagno N, Pirmadjid N, Sadrai Z, Chauhan SK, Dana R. Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis. Invest Ophthalmol Vis Sci. 2016 Mar; 57(3):1457-67. PMID: 27031839; PMCID: PMC4819620.
  64. Tahvildari M, Omoto M, Chen Y, Emami-Naeini P, Inomata T, Dohlman TH, Kaye AE, Chauhan SK, Dana R. In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation. Transplantation. 2016 Mar; 100(3):525-32. PMID: 26881788; PMCID: PMC4764457 [Available on 03/01/17].
  65. Kheirkhah A, Saboo US, Marmalidou A, Dana R. Overestimation of Corneal Endothelial Cell Density in Smaller Frame Sizes in In Vivo Confocal Microscopy. Cornea. 2016 Mar; 35(3):363-9. PMID: 26606299.
    View in: PubMed
  66. Kheirkhah A, Rahimi Darabad R, Cruzat A, Hajrasouliha AR, Witkin D, Wong N, Dana R, Hamrah P. Corneal Epithelial Immune Dendritic Cell Alterations in Subtypes of Dry Eye Disease: A Pilot In Vivo Confocal Microscopic Study. Invest Ophthalmol Vis Sci. 2015 Nov; 56(12):7179-85. PMID: 26540656; PMCID: PMC4640475.
  67. Heindl LM, Kaser-Eichberger A, Schlereth SL, Bock F, Regenfuss B, Reitsamer HA, McMenamin P, Lutty GA, Maruyama K, Chen L, Dana R, Kerjaschki D, Alitalo K, De Stefano ME, Junghans BM, Schroedl F, Cursiefen C. Sufficient Evidence for Lymphatics in the Developing and Adult Human Choroid? Invest Ophthalmol Vis Sci. 2015 Oct; 56(11):6709-10. PMID: 26588256; PMCID: PMC4911099.
  68. Cruzat A, Schrems WA, Schrems-Hoesl LM, Cavalcanti BM, Baniasadi N, Witkin D, Pavan-Langston D, Dana R, Hamrah P. Contralateral Clinically Unaffected Eyes of Patients With Unilateral Infectious Keratitis Demonstrate a Sympathetic Immune Response. Invest Ophthalmol Vis Sci. 2015 Oct; 56(11):6612-20. PMID: 26465889; PMCID: PMC4611956.
  69. Inomata T, Mashaghi A, Di Zazzo A, Dana R. Ocular surgical models for immune and angiogenic responses. J Biol Methods. 2015; 2(3). PMID: 26550579.
    View in: PubMed
  70. Müller RT, Abedi F, Cruzat A, Witkin D, Baniasadi N, Cavalcanti BM, Jamali A, Chodosh J, Dana R, Pavan-Langston D, Hamrah P. Degeneration and Regeneration of Subbasal Corneal Nerves after Infectious Keratitis: A Longitudinal In Vivo Confocal Microscopy Study. Ophthalmology. 2015 Nov; 122(11):2200-9. PMID: 26256833; PMCID: PMC4623997 [Available on 11/01/16].
  71. Chauhan SK, Lee HK, Lee HS, Park EY, Jeong E, Dana R. PTK7+ Mononuclear Cells Express VEGFR2 and Contribute to Vascular Stabilization by Upregulating Angiopoietin-1. Arterioscler Thromb Vasc Biol. 2015 Jul; 35(7):1606-15. PMID: 25997931; PMCID: PMC4483153.
  72. Saboo US, Amparo F, Abud TB, Schaumberg DA, Dana R. Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease. Ophthalmology. 2015 Aug; 122(8):1669-74. PMID: 26001816; PMCID: PMC4516685.
  73. Lee HS, Hos D, Blanco T, Bock F, Reyes NJ, Mathew R, Cursiefen C, Dana R, Saban DR. Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease. Invest Ophthalmol Vis Sci. 2015 May; 56(5):3140-8. PMID: 26024097; PMCID: PMC4451613.
  74. Amparo F, Schaumberg DA, Dana R. Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry Eye. Ophthalmology. 2015 Jul; 122(7):1498-503. PMID: 25863420; PMCID: PMC4485570.
  75. Dohlman TH, Omoto M, Hua J, Stevenson W, Lee SM, Chauhan SK, Dana R. VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation. Transplantation. 2015 Apr; 99(4):678-86. PMID: 25606789.
    View in: PubMed
  76. Kheirkhah A, Saboo US, Abud TB, Dohlman TH, Arnoldner MA, Hamrah P, Dana R. Reduced Corneal Endothelial Cell Density in Patients With Dry Eye Disease. Am J Ophthalmol. 2015 Jun; 159(6):1022-1026.e2. PMID: 25782347; PMCID: PMC4427236.
  77. Hamrah P, Sahin A, Dastjerdi MH, Shahatit BM, Bayhan HA, Dana R, Pavan-Langston D. In Vivo confocal microscopic changes of the corneal epithelium and stroma in patients with herpes zoster ophthalmicus. Am J Ophthalmol. 2015 Jun; 159(6):1036-1044.e1. PMID: 25748579; PMCID: PMC4788981.
  78. Shikari H, Amparo F, Saboo U, Dana R. Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea. 2015 Mar; 34(3):243-7. PMID: 25603230; PMCID: PMC4318713.
  79. Uchino Y, Mauris J, Woodward AM, Dieckow J, Amparo F, Dana R, Mantelli F, Argüeso P. Alteration of galectin-3 in tears of patients with dry eye disease. Am J Ophthalmol. 2015 Jun; 159(6):1027-1035.e3. PMID: 25703476; PMCID: PMC4426220.
  80. Saboo US, Amparo F, Shikari H, Jurkunas UV, Dana R. Outcomes of phacoemulsification in patients with chronic ocular graft-versus-host disease. Graefes Arch Clin Exp Ophthalmol. 2015 Jun; 253(6):901-7. PMID: 25619668; PMCID: PMC4447562.
  81. Kheirkhah A, Dohlman TH, Amparo F, Arnoldner MA, Jamali A, Hamrah P, Dana R. Effects of corneal nerve density on the response to treatment in dry eye disease. Ophthalmology. 2015 Apr; 122(4):662-8. PMID: 25542519; PMCID: PMC4372494.
  82. Crnej A, Omoto M, Dohlman TH, Dohlman CH, Dana R. Corneal inflammation after miniature keratoprosthesis implantation. Invest Ophthalmol Vis Sci. 2014 Dec 16; 56(1):185-9. PMID: 25515579; PMCID: PMC4290558.
  83. Stevenson W, Chen Y, Lee SM, Lee HS, Hua J, Dohlman T, Shiang T, Dana R. Extraorbital lacrimal gland excision: a reproducible model of severe aqueous tear-deficient dry eye disease. Cornea. 2014 Dec; 33(12):1336-41. PMID: 25255136.
    View in: PubMed
  84. Schroedl F, Kaser-Eichberger A, Schlereth SL, Bock F, Regenfuss B, Reitsamer HA, Lutty GA, Maruyama K, Chen L, Lütjen-Drecoll E, Dana R, Kerjaschki D, Alitalo K, De Stefano ME, Junghans BM, Heindl LM, Cursiefen C. Consensus statement on the immunohistochemical detection of ocular lymphatic vessels. Invest Ophthalmol Vis Sci. 2014 Oct 14; 55(10):6440-2. PMID: 25315233; PMCID: PMC4580075.
  85. Hua J, Jin Y, Chen Y, Inomata T, Lee H, Chauhan SK, Petasis NA, Serhan CN, Dana R. The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. Invest Ophthalmol Vis Sci. 2014 Aug 21; 55(9):5944-51. PMID: 25146982; PMCID: PMC4172301.
  86. Kodati S, Chauhan SK, Chen Y, Dohlman TH, Karimian P, Saban D, Dana R. CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease. Invest Ophthalmol Vis Sci. 2014 Aug 19; 55(9):5871-7. PMID: 25139737; PMCID: PMC4168741.
  87. Emami-Naeini P, Dohlman TH, Omoto M, Hattori T, Chen Y, Lee HS, Chauhan SK, Dana R. Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival. Graefes Arch Clin Exp Ophthalmol. 2014 Nov; 252(11):1755-62. PMID: 25091513; PMCID: PMC4221529.
  88. Crnej A, Omoto M, Dohlman TH, Graney JM, Dohlman CH, Drnovsek-Olup B, Dana R. A novel murine model for keratoprosthesis. Invest Ophthalmol Vis Sci. 2014 May 15; 55(6):3681-5. PMID: 24833747; PMCID: PMC4059078.
  89. Jakobiec FA, Rashid A, Bozorg MS, Dana R. Unusual large uniocular elastoid and collagenous pinguecula. Graefes Arch Clin Exp Ophthalmol. 2014 Jul; 252(7):1173-5. PMID: 24807233.
    View in: PubMed
  90. Lee H, Schlereth SL, Park EY, Emami-Naeini P, Chauhan SK, Dana R. A novel pro-angiogenic function for interferon-?-secreting natural killer cells. Invest Ophthalmol Vis Sci. 2014 May 02; 55(5):2885-92. PMID: 24713481; PMCID: PMC4010366.
  91. Amparo F, Hamrah P, Schaumberg DA, Dana R. The value of tear osmolarity as a metric in evaluating the response to dry eye therapy in the clinic and in clinical trials. Am J Ophthalmol. 2014 Apr; 157(4):915-6. PMID: 24630207.
    View in: PubMed
  92. Cade F, Paschalis EI, Regatieri CV, Vavvas DG, Dana R, Dohlman CH. Alkali burn to the eye: protection using TNF-a inhibition. Cornea. 2014 Apr; 33(4):382-9. PMID: 24488127.
    View in: PubMed
  93. Katikireddy KR, Dana R, Jurkunas UV. Differentiation potential of limbal fibroblasts and bone marrow mesenchymal stem cells to corneal epithelial cells. Stem Cells. 2014 Mar; 32(3):717-29. PMID: 24022965.
    View in: PubMed
  94. Stevenson W, Sadrai Z, Hua J, Kodati S, Huang JF, Chauhan SK, Dana R. Effects of topical Janus kinase inhibition on ocular surface inflammation and immunity. Cornea. 2014 Feb; 33(2):177-83. PMID: 24342887.
    View in: PubMed
  95. Chauhan SK, Dohlman TH, Dana R. Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity. J Clin Cell Immunol. 2014; 5. PMID: 25580370.
    View in: PubMed
  96. Hajrasouliha AR, Sadrai Z, Lee HK, Chauhan SK, Dana R. Expression of the chemokine decoy receptor D6 mediates dendritic cell function and promotes corneal allograft rejection. Mol Vis. 2013; 19:2517-25. PMID: 24357920; PMCID: PMC3867163.
  97. Chauhan SK, Saban DR, Dohlman TH, Dana R. CCL-21 conditioned regulatory T cells induce allotolerance through enhanced homing to lymphoid tissue. J Immunol. 2014 Jan 15; 192(2):817-23. PMID: 24337379; PMCID: PMC3947335.
  98. Ogawa Y, Kim SK, Dana R, Clayton J, Jain S, Rosenblatt MI, Perez VL, Shikari H, Riemens A, Tsubota K. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep. 2013 Dec 05; 3:3419. PMID: 24305504; PMCID: PMC3851919.
  99. Dana R, Miller JW. On the edge: the clinician-scientist in ophthalmology. JAMA Ophthalmol. 2013 Nov; 131(11):1401-2. PMID: 24077531.
    View in: PubMed
  100. Stevenson W, Shikari H, Saboo US, Amparo F, Dana R. Bilateral corneal ulceration in ocular graft-versus-host disease. Clin Ophthalmol. 2013; 7:2153-8. PMID: 24204119; PMCID: PMC3817064.
  101. Amparo F, Jin Y, Hamrah P, Schaumberg DA, Dana R. What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease? Am J Ophthalmol. 2014 Jan; 157(1):69-77.e2. PMID: 24060433; PMCID: PMC3865167.
  102. Amparo F, Wang H, Emami-Naeini P, Karimian P, Dana R. The Ocular Redness Index: a novel automated method for measuring ocular injection. Invest Ophthalmol Vis Sci. 2013 Jul 18; 54(7):4821-6. PMID: 23766472; PMCID: PMC3720148.
  103. Ferrari G, Dastjerdi MH, Okanobo A, Cheng SF, Amparo F, Nallasamy N, Dana R. Topical ranibizumab as a treatment of corneal neovascularization. Cornea. 2013 Jul; 32(7):992-7. PMID: 23407316; PMCID: PMC3920979.
  104. Cheng SF, Dastjerdi MH, Ferrari G, Okanobo A, Amparo F, Stevenson W, Hamrah P, Nallasamy N, Dana R, Bower KS, Ryan DS. Reply: To PMID 22967868. Am J Ophthalmol. 2013 Jul; 156(1):204-5. PMID: 23791375; PMCID: PMC4515427.
  105. Ferrari G, Nallasamy N, Downs H, Dana R, Oaklander AL. Corneal innervation as a window to peripheral neuropathies. Exp Eye Res. 2013 08; 113:148-50. PMID: 23769950; PMCID: PMC3737766.
  106. Dohlman TH, Chauhan SK, Kodati S, Hua J, Chen Y, Omoto M, Sadrai Z, Dana R. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Invest Ophthalmol Vis Sci. 2013 Jun 12; 54(6):4081-91. PMID: 23702781; PMCID: PMC3681477.
  107. Amparo F, Dastjerdi MH, Okanobo A, Ferrari G, Smaga L, Hamrah P, Jurkunas U, Schaumberg DA, Dana R. Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. JAMA Ophthalmol. 2013 Jun; 131(6):715-723. PMID: 23599118; PMCID: PMC4167802.
  108. Chen Y, Chauhan SK, Lee HS, Stevenson W, Schaumburg CS, Sadrai Z, Saban DR, Kodati S, Stern ME, Dana R. Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Invest Ophthalmol Vis Sci. 2013 Apr 03; 54(4):2457-64. PMID: 23482465; PMCID: PMC3623599.
  109. Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013 May-Jun; 58(3):233-51. PMID: 23541042.
    View in: PubMed
  110. Ferrari G, Hajrasouliha AR, Sadrai Z, Ueno H, Chauhan SK, Dana R. Nerves and neovessels inhibit each other in the cornea. Invest Ophthalmol Vis Sci. 2013 Jan 28; 54(1):813-20. PMID: 23307967; PMCID: PMC3562120.
  111. Amparo F, Sadrai Z, Jin Y, Alfonso-Bartolozzi B, Wang H, Shikari H, Ciolino JB, Chodosh J, Jurkunas U, Schaumberg DA, Dana R. Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization. Invest Ophthalmol Vis Sci. 2013 Jan 17; 54(1):537-44. PMID: 23233252; PMCID: PMC3558296.
  112. Stevenson W, Cheng SF, Emami-Naeini P, Hua J, Paschalis EI, Dana R, Saban DR. Gamma-irradiation reduces the allogenicity of donor corneas. Invest Ophthalmol Vis Sci. 2012 Oct 01; 53(11):7151-8. PMID: 22991417; PMCID: PMC3474589.
  113. Dana R. Normobaric oxygen therapy. J Ophthalmic Vis Res. 2012 Oct; 7(4):273-4. PMID: 23505595; PMCID: PMC3595587.
  114. Ferrari G, Ueno H, Bignami F, Rama P, Dana R. Trigeminal stereotactic electrolysis induces dry eye in mice. Acta Ophthalmol. 2013 Mar; 91(2):e162-3. PMID: 22998727; PMCID: PMC3676178.
  115. Hamrah P, Cruzat A, Dastjerdi MH, Prüss H, Zheng L, Shahatit BM, Bayhan HA, Dana R, Pavan-Langston D. Unilateral herpes zoster ophthalmicus results in bilateral corneal nerve alteration: an in vivo confocal microscopy study. Ophthalmology. 2013 Jan; 120(1):40-7. PMID: 22999636.
    View in: PubMed
  116. Cheng SF, Dastjerdi MH, Ferrari G, Okanobo A, Bower KS, Ryan DS, Amparo F, Stevenson W, Hamrah P, Nallasamy N, Dana R. Short-term topical bevacizumab in the treatment of stable corneal neovascularization. Am J Ophthalmol. 2012 Dec; 154(6):940-948.e1. PMID: 22967868; PMCID: PMC3498533.
  117. Sharma SM, Fuchsluger T, Ahmad S, Katikireddy KR, Armant M, Dana R, Jurkunas UV. Comparative analysis of human-derived feeder layers with 3T3 fibroblasts for the ex vivo expansion of human limbal and oral epithelium. Stem Cell Rev. 2012 Sep; 8(3):696-705. PMID: 21964568.
    View in: PubMed
  118. Lee HS, Hattori T, Park EY, Stevenson W, Chauhan SK, Dana R. Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Invest Ophthalmol Vis Sci. 2012 Aug 17; 53(9):5632-40. PMID: 22789921; PMCID: PMC3711695.
  119. Shim J, Park C, Lee HS, Park MS, Lim HT, Chauhan S, Dana R, Lee H, Lee HK. Change in prostaglandin expression levels and synthesizing activities in dry eye disease. Ophthalmology. 2012 Nov; 119(11):2211-9. PMID: 22858125; PMCID: PMC3689228.
  120. Hajrasouliha AR, Sadrai Z, Chauhan SK, Dana R. b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern. Cornea. 2012 Jul; 31(7):804-9. PMID: 22467003; PMCID: PMC3669545.
  121. Sadrai Z, Stevenson W, Okanobo A, Chen Y, Dohlman TH, Hua J, Amparo F, Chauhan SK, Dana R. PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease. Invest Ophthalmol Vis Sci. 2012 Jun 14; 53(7):3584-91. PMID: 22577075; PMCID: PMC3406885.
  122. Hamrah P, Sahin A, Dastjerdi MH, Shahatit BM, Bayhan HA, Dana R, Pavan-Langston D. Cellular changes of the corneal epithelium and stroma in herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology. 2012 Sep; 119(9):1791-7. PMID: 22608476; PMCID: PMC3426622.
  123. Okanobo A, Chauhan SK, Dastjerdi MH, Kodati S, Dana R. Efficacy of topical blockade of interleukin-1 in experimental dry eye disease. Am J Ophthalmol. 2012 Jul; 154(1):63-71. PMID: 22541929; PMCID: PMC3378826.
  124. Hajrasouliha AR, Funaki T, Sadrai Z, Hattori T, Chauhan SK, Dana R. Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis. Invest Ophthalmol Vis Sci. 2012 Mar; 53(3):1244-50. PMID: 22281820; PMCID: PMC3339906.
  125. Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012 May; 31(3):271-85. PMID: 22426080; PMCID: PMC3334398.
  126. Ueno H, Ferrari G, Hattori T, Saban DR, Katikireddy KR, Chauhan SK, Dana R. Dependence of corneal stem/progenitor cells on ocular surface innervation. Invest Ophthalmol Vis Sci. 2012 Feb 21; 53(2):867-72. PMID: 22232434; PMCID: PMC3317425.
  127. Hattori T, Saban DR, Emami-Naeini P, Chauhan SK, Funaki T, Ueno H, Dana R. Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. J Leukoc Biol. 2012 Apr; 91(4):621-7. PMID: 22291211; PMCID: PMC3317274.
  128. Stevenson W, Cheng SF, Dastjerdi MH, Ferrari G, Dana R. Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf. 2012 Apr; 10(2):67-83. PMID: 22482468; PMCID: PMC3471139.
  129. Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012 Jan; 130(1):90-100. PMID: 22232476; PMCID: PMC3677724.
  130. Lee HS, Chauhan SK, Okanobo A, Nallasamy N, Dana R. Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. Cornea. 2011 Dec; 30(12):1465-72. PMID: 21993466; PMCID: PMC3703663.
  131. Dastjerdi MH, Sadrai Z, Saban DR, Zhang Q, Dana R. Corneal penetration of topical and subconjunctival bevacizumab. Invest Ophthalmol Vis Sci. 2011 Nov 07; 52(12):8718-23. PMID: 22003112; PMCID: PMC3230312.
  132. Goyal S, Chauhan SK, Dana R. Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease. Arch Ophthalmol. 2012 Jan; 130(1):84-9. PMID: 21911653; PMCID: PMC3629840.
  133. Chauhan SK, Jin Y, Goyal S, Lee HS, Fuchsluger TA, Lee HK, Dana R. A novel pro-lymphangiogenic function for Th17/IL-17. Blood. 2011 Oct 27; 118(17):4630-4. PMID: 21908425; PMCID: PMC3208279.
  134. Cruzat A, Witkin D, Baniasadi N, Zheng L, Ciolino JB, Jurkunas UV, Chodosh J, Pavan-Langston D, Dana R, Hamrah P. Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis. Invest Ophthalmol Vis Sci. 2011 Jul 11; 52(8):5136-43. PMID: 21460259; PMCID: PMC3176064.
  135. Clements JL, Dana R. Inflammatory corneal neovascularization: etiopathogenesis. Semin Ophthalmol. 2011 Jul-Sep; 26(4-5):235-45. PMID: 21958169.
    View in: PubMed
  136. Yoo JH, Chodosh J, Dana R. Relapsing polychondritis: systemic and ocular manifestations, differential diagnosis, management, and prognosis. Semin Ophthalmol. 2011 Jul-Sep; 26(4-5):261-9. PMID: 21958172.
    View in: PubMed
  137. Townley JR, Dana R, Jacobs DS. Keratoconjunctivitis sicca manifestations in ocular graft versus host disease: pathogenesis, presentation, prevention, and treatment. Semin Ophthalmol. 2011 Jul-Sep; 26(4-5):251-60. PMID: 21958171.
    View in: PubMed
  138. Hawthorne KM, Dana R, Chodosh J. Delayed type hypersensitivity in the pathogenesis of recurrent herpes stromal keratitis. Semin Ophthalmol. 2011 Jul-Sep; 26(4-5):246-50. PMID: 21958170.
    View in: PubMed
  139. Cursiefen C, Colin J, Dana R, Diaz-Llopis M, Faraj LA, Garcia-Delpech S, Geerling G, Price FW, Remeijer L, Rouse BT, Seitz B, Udaondo P, Meller D, Dua H. Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. Br J Ophthalmol. 2012 Jan; 96(1):3-9. PMID: 21712359.
    View in: PubMed
  140. Hattori T, Chauhan SK, Lee H, Ueno H, Dana R, Kaplan DH, Saban DR. Characterization of Langerin-expressing dendritic cell subsets in the normal cornea. Invest Ophthalmol Vis Sci. 2011 Jun 28; 52(7):4598-604. PMID: 21482644; PMCID: PMC3175952.
  141. Cursiefen C, Maruyama K, Bock F, Saban D, Sadrai Z, Lawler J, Dana R, Masli S. Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J Exp Med. 2011 May 09; 208(5):1083-92. PMID: 21536744; PMCID: PMC3092349.
  142. Ferrari G, Chauhan SK, Ueno H, Nallasamy N, Gandolfi S, Borges L, Dana R. A novel mouse model for neurotrophic keratopathy: trigeminal nerve stereotactic electrolysis through the brain. Invest Ophthalmol Vis Sci. 2011 Apr; 52(5):2532-9. PMID: 21071731; PMCID: PMC3088548.
  143. Sadrai Z, Hajrasouliha AR, Chauhan S, Saban DR, Dastjerdi MH, Dana R. Effect of topical azithromycin on corneal innate immune responses. Invest Ophthalmol Vis Sci. 2011 Apr 19; 52(5):2525-31. PMID: 21296809; PMCID: PMC3262402.
  144. Jin Y, Chauhan SK, El Annan J, Annan JE, Sage PT, Sharpe AH, Dana R. A novel function for programmed death ligand-1 regulation of angiogenesis. Am J Pathol. 2011 Apr; 178(4):1922-9. PMID: 21435468; PMCID: PMC3078456.
  145. Lee HK, Chauhan SK, Kay E, Dana R. Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway. Blood. 2011 May 26; 117(21):5762-71. PMID: 21460247; PMCID: PMC3110033.
  146. Asbell PA, Stapleton FJ, Wickström K, Akpek EK, Aragona P, Dana R, Lemp MA, Nichols KK. The international workshop on meibomian gland dysfunction: report of the clinical trials subcommittee. Invest Ophthalmol Vis Sci. 2011 Mar; 52(4):2065-85. PMID: 21450920; PMCID: PMC3072164.
  147. Fuchsluger TA, Jurkunas U, Kazlauskas A, Dana R. Corneal endothelial cells are protected from apoptosis by gene therapy. Hum Gene Ther. 2011 May; 22(5):549-58. PMID: 21158568; PMCID: PMC3081440.
  148. Chen Y, Chauhan SK, Saban DR, Sadrai Z, Okanobo A, Dana R. Interferon-?-secreting NK cells promote induction of dry eye disease. J Leukoc Biol. 2011 Jun; 89(6):965-72. PMID: 21402771; PMCID: PMC3100760.
  149. Ahmad S, Osei-Bempong C, Dana R, Jurkunas U. The culture and transplantation of human limbal stem cells. J Cell Physiol. 2010 Oct; 225(1):15-9. PMID: 20506173.
    View in: PubMed
  150. Saban DR, Bock F, Chauhan SK, Masli S, Dana R. Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. J Immunol. 2010 Oct 15; 185(8):4691-7. PMID: 20844200; PMCID: PMC3090006.
  151. Hamrah P, Cruzat A, Dastjerdi MH, Zheng L, Shahatit BM, Bayhan HA, Dana R, Pavan-Langston D. Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology. 2010 Oct; 117(10):1930-6. PMID: 20810171; PMCID: PMC2949523.
  152. Goyal S, Chauhan SK, El Annan J, Nallasamy N, Zhang Q, Dana R. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol. 2010 Jul; 128(7):819-24. PMID: 20625040; PMCID: PMC3089983.
  153. El Annan J, Goyal S, Zhang Q, Freeman GJ, Sharpe AH, Dana R. Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation. Invest Ophthalmol Vis Sci. 2010 Jul; 51(7):3418-23. PMID: 20019373; PMCID: PMC3979489.
  154. Dastjerdi MH, Hamrah P, Dana R. High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen. Cornea. 2009 Dec; 28(10):1091-6. PMID: 19770713; PMCID: PMC2924632.
  155. Dastjerdi MH, Saban DR, Okanobo A, Nallasamy N, Sadrai Z, Chauhan SK, Hajrasouliha AR, Dana R. Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Invest Ophthalmol Vis Sci. 2010 May; 51(5):2411-7. PMID: 19892863; PMCID: PMC2868492.
  156. Chung ES, Chauhan SK, Jin Y, Nakao S, Hafezi-Moghadam A, van Rooijen N, Zhang Q, Chen L, Dana R. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol. 2009 Nov; 175(5):1984-92. PMID: 19808642; PMCID: PMC2774062.
  157. Jin Y, Chauhan SK, Saban DR, Dana R. Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation. Invest Ophthalmol Vis Sci. 2010 Feb; 51(2):816-21. PMID: 19797201; PMCID: PMC2868459.
  158. Skobe M, Dana R. Blocking the path of lymphatic vessels. Nat Med. 2009 Sep; 15(9):993-4. PMID: 19734869; PMCID: PMC2924617.
  159. Hamrah P, Haskova Z, Taylor AW, Zhang Q, Ksander BR, Dana MR. Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection. Transplantation. 2009 Jul 27; 88(2):180-7. PMID: 19623012; PMCID: PMC2735785.
  160. Goyal S, Chauhan SK, Zhang Q, Dana R. Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. Arch Ophthalmol. 2009 Jul; 127(7):882-7. PMID: 19597109.
    View in: PubMed
  161. Chauhan SK, Dana R. Role of Th17 cells in the immunopathogenesis of dry eye disease. Mucosal Immunol. 2009 Jul; 2(4):375-6. PMID: 19532120; PMCID: PMC2719854.
  162. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol. 2009 Jun; 127(6):763-8. PMID: 19506195; PMCID: PMC2836718.
  163. Patel SP, Dana R. Corneal lymphangiogenesis: implications in immunity. Semin Ophthalmol. 2009 May-Jun; 24(3):135-8. PMID: 19437348.
    View in: PubMed
  164. Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, Serhan CN, Dana R. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci. 2009 Oct; 50(10):4743-52. PMID: 19407006; PMCID: PMC2763387.
  165. El Annan J, Chauhan SK, Ecoiffier T, Zhang Q, Saban DR, Dana R. Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci. 2009 Aug; 50(8):3802-7. PMID: 19339740; PMCID: PMC2921683.
  166. Dastjerdi MH, Al-Arfaj KM, Nallasamy N, Hamrah P, Jurkunas UV, Pineda R, Pavan-Langston D, Dana R. Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch Ophthalmol. 2009 Apr; 127(4):381-9. PMID: 19365012; PMCID: PMC2703579.
  167. Fabiani C, Barabino S, Rashid S, Dana MR. Corneal epithelial proliferation and thickness in a mouse model of dry eye. Exp Eye Res. 2009 Aug; 89(2):166-71. PMID: 19298814; PMCID: PMC2713794.
  168. Saban DR, Chauhan SK, Zhang X, El Annan J, Jin Y, Dana R. 'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival. Am J Transplant. 2009 Mar; 9(3):473-82. PMID: 19260831; PMCID: PMC2839405.
  169. Bachmann BO, Luetjen-Drecoll E, Bock F, Wiegand SJ, Hos D, Dana R, Kruse FE, Cursiefen C. Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation. Br J Ophthalmol. 2009 Aug; 93(8):1075-80. PMID: 19224901.
    View in: PubMed
  170. Chauhan SK, El Annan J, Ecoiffier T, Goyal S, Zhang Q, Saban DR, Dana R. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol. 2009 Feb 01; 182(3):1247-52. PMID: 19155469; PMCID: PMC2630586.
  171. Boisgérault F, Liu Y, Anosova N, Dana R, Benichou G. Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation. 2009 Jan 15; 87(1):16-23. PMID: 19136886; PMCID: PMC2698296.
  172. Zhang X, Shen L, Jin Y, Saban DR, Chauhan SK, Dana R. Depletion of passenger leukocytes from corneal grafts: an effective means of promoting transplant survival? Invest Ophthalmol Vis Sci. 2009 Jul; 50(7):3137-44. PMID: 19136708; PMCID: PMC2739689.
  173. Chauhan SK, Saban DR, Lee HK, Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol. 2009 Jan 01; 182(1):148-53. PMID: 19109145; PMCID: PMC2610348.
  174. Hamrah P, Pavan-Langston D, Dana R. Herpes simplex keratitis and dendritic cells at the crossroads: lessons from the past and a view into the future. Int Ophthalmol Clin. 2009; 49(1):53-62. PMID: 19125064; PMCID: PMC4313552.
  175. Dastjerdi MH, Dana R. Corneal nerve alterations in dry eye-associated ocular surface disease. Int Ophthalmol Clin. 2009; 49(1):11-20. PMID: 19125060.
    View in: PubMed
  176. Lam H, Dana MR. Corneal graft rejection. Int Ophthalmol Clin. 2009; 49(1):31-41. PMID: 19125062.
    View in: PubMed
  177. Hatch KM, Dana R. The structure and function of the limbal stem cell and the disease states associated with limbal stem cell deficiency. Int Ophthalmol Clin. 2009; 49(1):43-52. PMID: 19125063.
    View in: PubMed
  178. Ecoiffier T, El Annan J, Rashid S, Schaumberg D, Dana R. Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease. Arch Ophthalmol. 2008 Dec; 126(12):1695-9. PMID: 19064851.
    View in: PubMed
  179. Chung ES, Saban DR, Chauhan SK, Dana R. Regulation of blood vessel versus lymphatic vessel growth in the cornea. Invest Ophthalmol Vis Sci. 2009 Apr; 50(4):1613-8. PMID: 19029028; PMCID: PMC2702143.
  180. Mantelli F, Schaffer L, Dana R, Head SR, Argüeso P. Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling. Invest Ophthalmol Vis Sci. 2009 Jun; 50(6):2666-72. PMID: 19011014; PMCID: PMC2693254.
  181. Chong EM, Dana MR. Graft failure IV. Immunologic mechanisms of corneal transplant rejection. Int Ophthalmol. 2008 Jun; 28(3):209-22. PMID: 17673946.
    View in: PubMed
  182. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol. 2008 Feb; 126(2):219-25. PMID: 18268213.
    View in: PubMed
  183. Bachmann BO, Bock F, Wiegand SJ, Maruyama K, Dana MR, Kruse FE, Luetjen-Drecoll E, Cursiefen C. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol. 2008 Jan; 126(1):71-7. PMID: 18195221.
    View in: PubMed
  184. Harissi-Dagher M, Dana MR, Jurkunas UV. Keratoglobus in association with posterior polymorphous dystrophy. Cornea. 2007 Dec; 26(10):1288-91. PMID: 18043197.
    View in: PubMed
  185. Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J Immunol. 2007 Sep 15; 179(6):3672-9. PMID: 17785803.
    View in: PubMed
  186. Nakao S, Hata Y, Miura M, Noda K, Kimura YN, Kawahara S, Kita T, Hisatomi T, Nakazawa T, Jin Y, Dana MR, Kuwano M, Ono M, Ishibashi T, Hafezi-Moghadam A. Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis. Am J Pathol. 2007 Sep; 171(3):1058-65. PMID: 17690185; PMCID: PMC1959485.
  187. Barcia RN, Dana MR, Kazlauskas A. Corneal graft rejection is accompanied by apoptosis of the endothelium and is prevented by gene therapy with bcl-xL. Am J Transplant. 2007 Sep; 7(9):2082-9. PMID: 17614980.
    View in: PubMed
  188. Collins JF, Dartt DA, Dana R. Mist delivery of eye medication to the anterior segment. Am J Ophthalmol. 2007 Jul; 144(1):137-9. PMID: 17601439.
    View in: PubMed
  189. Shen L, Barabino S, Taylor AW, Dana MR. Effect of the ocular microenvironment in regulating corneal dendritic cell maturation. Arch Ophthalmol. 2007 Jul; 125(7):908-15. PMID: 17620569; PMCID: PMC4698151.
  190. Chen L, Huq S, Gardner H, de Fougerolles AR, Barabino S, Dana MR. Very late antigen 1 blockade markedly promotes survival of corneal allografts. Arch Ophthalmol. 2007 Jun; 125(6):783-8. PMID: 17562989; PMCID: PMC2677688.
  191. Chen L, Hamrah P, Cursiefen C, Zhang Q, Pytowski B, Streilein JW, Dana MR. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. 2004. Ocul Immunol Inflamm. 2007 May-Jun; 15(3):275-8. PMID: 17613841.
    View in: PubMed
  192. Jin Y, Shen L, Chong EM, Hamrah P, Zhang Q, Chen L, Dana MR. The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis. 2007 Apr 27; 13:626-34. PMID: 17515886; PMCID: PMC2669510.
  193. Hamrah P, Yamagami S, Liu Y, Zhang Q, Vora SS, Lu B, Gerard CJ, Dana MR. Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival. Invest Ophthalmol Vis Sci. 2007 Mar; 48(3):1228-36. PMID: 17325167; PMCID: PMC1868492.
  194. Barabino S, Rolando M, Chen L, Dana MR. Exposure to a dry environment induces strain-specific responses in mice. Exp Eye Res. 2007 May; 84(5):973-7. PMID: 17397831.
    View in: PubMed
  195. Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007 Mar; 143(3):409-15. PMID: 17317388; PMCID: PMC1847608.
  196. Rashid S, Dana MR. Cicatrizing and autoimmune diseases. Chem Immunol Allergy. 2007; 92:195-202. PMID: 17264495.
    View in: PubMed
  197. Hamrah P, Dana MR. Corneal antigen-presenting cells. Chem Immunol Allergy. 2007; 92:58-70. PMID: 17264483.
    View in: PubMed
  198. Barabino S, Dana MR. Dry eye syndromes. Chem Immunol Allergy. 2007; 92:176-84. PMID: 17264493.
    View in: PubMed
  199. Chong EM, Dana MR. Acanthamoeba keratitis. Int Ophthalmol Clin. 2007; 47(2):33-46. PMID: 17450005.
    View in: PubMed
  200. Dana R. Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007; 105:330-43. PMID: 18427620; PMCID: PMC2258099.
  201. Schaumberg DA, Gulati A, Mathers WD, Clinch T, Lemp MA, Nelson JD, Foulks GN, Dana R. Development and validation of a short global dry eye symptom index. Ocul Surf. 2007 Jan; 5(1):50-7. PMID: 17252166.
    View in: PubMed
  202. Sullivan BD, Evans JE, Dana MR, Sullivan DA. Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol. 2006 Sep; 124(9):1286-92. PMID: 16966624.
    View in: PubMed
  203. Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid S, Pytowski B, Persaud K, Wu Y, Streilein JW, Dana R. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A. 2006 Jul 25; 103(30):11405-10. PMID: 16849433; PMCID: PMC1544098.
  204. Gulati A, Sullivan R, Buring JE, Sullivan DA, Dana R, Schaumberg DA. Validation and repeatability of a short questionnaire for dry eye syndrome. Am J Ophthalmol. 2006 Jul; 142(1):125-131. PMID: 16815260.
    View in: PubMed
  205. Beauregard C, Huq SO, Barabino S, Zhang Q, Kazlauskas A, Dana MR. Keratocyte apoptosis and failure of corneal allografts. Transplantation. 2006 Jun 15; 81(11):1577-82. PMID: 16770247; PMCID: PMC1479606.
  206. Gulati A, Sacchetti M, Bonini S, Dana R. Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. Arch Ophthalmol. 2006 May; 124(5):710-6. PMID: 16682594.
    View in: PubMed
  207. Tsai PS, Evans JE, Green KM, Sullivan RM, Schaumberg DA, Richards SM, Dana MR, Sullivan DA. Proteomic analysis of human meibomian gland secretions. Br J Ophthalmol. 2006 Mar; 90(3):372-7. PMID: 16488965; PMCID: PMC1856970.
  208. Dana R, Nussenblatt R, Gordon L. Advances in immunology: from bench to bedside--a symposium at the 2005 Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), Boston, MA, USA. Ocul Immunol Inflamm. 2006 Feb; 14(1):1-6. PMID: 16507484.
    View in: PubMed
  209. Dana MR. Angiogenesis and lymphangiogenesis-implications for corneal immunity. Semin Ophthalmol. 2006 Jan-Mar; 21(1):19-22. PMID: 16517440.
    View in: PubMed
  210. Chen L, Cursiefen C, Barabino S, Zhang Q, Dana MR. Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells. Invest Ophthalmol Vis Sci. 2005 Dec; 46(12):4536-40. PMID: 16303945; PMCID: PMC1397798.
  211. Barabino S, Raghavan A, Loeffler J, Dana R. Radiotherapy-induced ocular surface disease. Cornea. 2005 Nov; 24(8):909-14. PMID: 16227831.
    View in: PubMed
  212. Balaram M, Rashid S, Dana R. Chronic ocular surface disease after allogeneic bone marrow transplantation. Ocul Surf. 2005 Oct; 3(4):203-11. PMID: 17131029.
    View in: PubMed
  213. Dana R. Corneal antigen presentation: molecular regulation and functional implications. Ocul Surf. 2005 Oct; 3(4 Suppl):S169-72. PMID: 17216112.
    View in: PubMed
  214. McDermott AM, Perez V, Huang AJ, Pflugfelder SC, Stern ME, Baudouin C, Beuerman RW, Burns AR, Calder VL, Calonge M, Chodosh J, Coster DJ, Dana R, Hazlett LD, Jones DB, Kim SK, Knop E, Li DQ, Mitchell BM, Niederkorn JY, Pearlman E, Wilhelmus KR, Kurie E. Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf. 2005 Oct; 3(4 Suppl):S131-8. PMID: 17216102.
    View in: PubMed
  215. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005 Oct; 82(4):887-93. PMID: 16210721.
    View in: PubMed
  216. Yamagami S, Hamrah P, Zhang Q, Liu Y, Huq S, Dana MR. Early ocular chemokine gene expression and leukocyte infiltration after high-risk corneal transplantation. Mol Vis. 2005 Aug 29; 11:632-40. PMID: 16145544.
    View in: PubMed
  217. Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR. The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci. 2005 Aug; 46(8):2766-71. PMID: 16043849.
    View in: PubMed
  218. Cursiefen C, Ikeda S, Nishina PM, Smith RS, Ikeda A, Jackson D, Mo JS, Chen L, Dana MR, Pytowski B, Kruse FE, Streilein JW. Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling. Am J Pathol. 2005 May; 166(5):1367-77. PMID: 15855638; PMCID: PMC1606392.
  219. Yi DH, Rashid S, Cibas ES, Arrigg PG, Dana MR. Acute unilateral leukemic hypopyon in an adult with relapsing acute lymphoblastic leukemia. Am J Ophthalmol. 2005 Apr; 139(4):719-21. PMID: 15808176.
    View in: PubMed
  220. Yamagami S, Hamrah P, Miyamoto K, Miyazaki D, Dekaris I, Dawson T, Lu B, Gerard C, Dana MR. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium. Invest Ophthalmol Vis Sci. 2005 Apr; 46(4):1201-7. PMID: 15790880.
    View in: PubMed
  221. Schaumberg DA, Mendes F, Balaram M, Dana MR, Sparrow D, Hu H. Accumulated lead exposure and risk of age-related cataract in men. JAMA. 2004 Dec 08; 292(22):2750-4. PMID: 15585735.
    View in: PubMed
  222. Barabino S, Chen W, Dana MR. Tear film and ocular surface tests in animal models of dry eye: uses and limitations. Exp Eye Res. 2004 Nov; 79(5):613-21. PMID: 15500820.
    View in: PubMed
  223. Hamrah P, Chen L, Cursiefen C, Zhang Q, Joyce NC, Dana MR. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp Eye Res. 2004 Oct; 79(4):553-61. PMID: 15381039.
    View in: PubMed
  224. Huq S, Liu Y, Benichou G, Dana MR. Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed microenvironment. J Immunol. 2004 Oct 01; 173(7):4464-9. PMID: 15383577.
    View in: PubMed
  225. Cursiefen C, Cao J, Chen L, Liu Y, Maruyama K, Jackson D, Kruse FE, Wiegand SJ, Dana MR, Streilein JW. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004 Aug; 45(8):2666-73. PMID: 15277490.
    View in: PubMed
  226. Chen L, Hamrah P, Cursiefen C, Zhang Q, Pytowski B, Streilein JW, Dana MR. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med. 2004 Aug; 10(8):813-5. PMID: 15235599.
    View in: PubMed
  227. Qian Y, Leong FL, Kazlauskas A, Dana MR. Ex vivo adenovirus-mediated gene transfer to corneal graft endothelial cells in mice. Invest Ophthalmol Vis Sci. 2004 Jul; 45(7):2187-93. PMID: 15223794.
    View in: PubMed
  228. Barabino S, Dana MR. Animal models of dry eye: a critical assessment of opportunities and limitations. Invest Ophthalmol Vis Sci. 2004 Jun; 45(6):1641-6. PMID: 15161821.
    View in: PubMed
  229. Cursiefen C, Masli S, Ng TF, Dana MR, Bornstein P, Lawler J, Streilein JW. Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. Invest Ophthalmol Vis Sci. 2004 Apr; 45(4):1117-24. PMID: 15037577.
    View in: PubMed
  230. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D'Amore PA, Dana MR, Wiegand SJ, Streilein JW. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004 Apr; 113(7):1040-50. PMID: 15057311; PMCID: PMC379325.
  231. Dana MR. Corneal antigen-presenting cells: diversity, plasticity, and disguise: the Cogan lecture. Invest Ophthalmol Vis Sci. 2004 Mar; 45(3):722-7; 721. PMID: 14985280.
    View in: PubMed
  232. Khadem J, Martino M, Anatelli F, Dana MR, Hamblin MR. Healing of perforating rat corneal incisions closed with photodynamic laser-activated tissue glue. Lasers Surg Med. 2004; 35(4):304-11. PMID: 15493025; PMCID: PMC3071689.
  233. Gardiner MF, Pineda R, Dana MR. Laser cataract surgery: past, present, and evolving technologies. Int Ophthalmol Clin. 2004; 44(1):113-21. PMID: 14704526.
    View in: PubMed
  234. Sullivan DA, Bélanger A, Cermak JM, Bérubé R, Papas AS, Sullivan RM, Yamagami H, Dana MR, Labrie F. Are women with Sjögren's syndrome androgen-deficient? J Rheumatol. 2003 Nov; 30(11):2413-9. PMID: 14677186.
    View in: PubMed
  235. Cermak JM, Krenzer KL, Sullivan RM, Dana MR, Sullivan DA. Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? Cornea. 2003 Aug; 22(6):516-21. PMID: 12883343.
    View in: PubMed
  236. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003 Aug; 136(2):318-26. PMID: 12888056.
    View in: PubMed
  237. Hamrah P, Liu Y, Zhang Q, Dana MR. Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol. 2003 Aug; 121(8):1132-40. PMID: 12912691.
    View in: PubMed
  238. Hamrah P, Huq SO, Liu Y, Zhang Q, Dana MR. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leukoc Biol. 2003 Aug; 74(2):172-8. PMID: 12885933.
    View in: PubMed
  239. Hamrah P, Chen L, Zhang Q, Dana MR. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am J Pathol. 2003 Jul; 163(1):57-68. PMID: 12819011; PMCID: PMC1868166.
  240. Mendes F, Schaumberg DA, Navon S, Steinert R, Sugar J, Holland EJ, Dana MR. Assessment of visual function after corneal transplantation: the quality of life and psychometric assessment after corneal transplantation (Q-PACT) study. Am J Ophthalmol. 2003 Jun; 135(6):785-93. PMID: 12788117.
    View in: PubMed
  241. Cursiefen C, Chen L, Dana MR, Streilein JW. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea. 2003 Apr; 22(3):273-81. PMID: 12658100.
    View in: PubMed
  242. Cursiefen C, Seitz B, Dana MR, Streilein JW. [Angiogenesis and lymphangiogenesis in the cornea. Pathogenesis, clinical implications and treatment options]. Ophthalmologe. 2003 Apr; 100(4):292-9. PMID: 12682761.
    View in: PubMed
  243. Cermak JM, Papas AS, Sullivan RM, Dana MR, Sullivan DA. Nutrient intake in women with primary and secondary Sjögren's syndrome. Eur J Clin Nutr. 2003 Feb; 57(2):328-34. PMID: 12571668.
    View in: PubMed
  244. Hamrah P, Liu Y, Zhang Q, Dana MR. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci. 2003 Feb; 44(2):581-9. PMID: 12556386.
    View in: PubMed
  245. Yamada J, Dana MR, Sotozono C, Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res. 2003 Feb; 76(2):161-7. PMID: 12565803.
    View in: PubMed
  246. Qian Y, Hamrah P, Boisgerault F, Yamagami S, Vora S, Benichou G, Dana MR. Mechanisms of immunotherapeutic intervention by anti-CD154 (CD40L) antibody in high-risk corneal transplantation. J Interferon Cytokine Res. 2002 Dec; 22(12):1217-25. PMID: 12581495.
    View in: PubMed
  247. Sullivan BD, Evans JE, Cermak JM, Krenzer KL, Dana MR, Sullivan DA. Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmol. 2002 Dec; 120(12):1689-99. PMID: 12470144.
    View in: PubMed
  248. Yi DH, Dana MR. Corneal edema after cataract surgery: incidence and etiology. Semin Ophthalmol. 2002 Sep-Dec; 17(3-4):110-4. PMID: 12759837.
    View in: PubMed
  249. Qian Y, Dana MR. Effect of locally administered anti-CD154 (CD40 ligand) monoclonal antibody on survival of allogeneic corneal transplants. Cornea. 2002 Aug; 21(6):592-7. PMID: 12131037.
    View in: PubMed
  250. Zierhut M, Dana MR, Stern ME, Sullivan DA. Immunology of the lacrimal gland and ocular tear film. Trends Immunol. 2002 Jul; 23(7):333-5. PMID: 12103343.
    View in: PubMed
  251. Suzuki T, Schaumberg DA, Sullivan BD, Liu M, Richards SM, Sullivan RM, Dana MR, Sullivan DA. Do estrogen and progesterone play a role in the dry eye of Sjögren's syndrome? Ann N Y Acad Sci. 2002 Jun; 966:223-5. PMID: 12114275.
    View in: PubMed
  252. Ohta K, Yamagami S, Wiggert B, Dana MR, Streilein JW. Chemokine gene expression in iris-ciliary body during experimental autoimmune uveoretinitis. Curr Eye Res. 2002 Jun; 24(6):451-7. PMID: 12525972.
    View in: PubMed
  253. Sullivan DA, Sullivan BD, Evans JE, Schirra F, Yamagami H, Liu M, Richards SM, Suzuki T, Schaumberg DA, Sullivan RM, Dana MR. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci. 2002 Jun; 966:211-22. PMID: 12114274.
    View in: PubMed
  254. Sakai R, Kinouchi T, Kawamoto S, Dana MR, Hamamoto T, Tsuru T, Okubo K, Yamagami S. Construction of human corneal endothelial cDNA library and identification of novel active genes. Invest Ophthalmol Vis Sci. 2002 Jun; 43(6):1749-56. PMID: 12036975.
    View in: PubMed
  255. Yamagami S, Dana MR, Tsuru T. Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation. Cornea. 2002 May; 21(4):405-9. PMID: 11973391.
    View in: PubMed
  256. Argüeso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome. Invest Ophthalmol Vis Sci. 2002 Apr; 43(4):1004-11. PMID: 11923240.
    View in: PubMed
  257. Hamrah P, Zhang Q, Liu Y, Dana MR. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci. 2002 Mar; 43(3):639-46. PMID: 11867578.
    View in: PubMed
  258. Liu Y, Hamrah P, Zhang Q, Taylor AW, Dana MR. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med. 2002 Jan 21; 195(2):259-68. PMID: 11805152; PMCID: PMC2193609.
  259. Sullivan BD, Evans JE, Dana MR, Sullivan DA. Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions. Adv Exp Med Biol. 2002; 506(Pt A):449-58. PMID: 12613945.
    View in: PubMed
  260. Hamrah P, Zhang Q, Dana MR. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in the conjunctiva--a potential link between lymphangiogenesis and leukocyte trafficking on the ocular surface. Adv Exp Med Biol. 2002; 506(Pt B):851-60. PMID: 12614002.
    View in: PubMed
  261. Sullivan DA, Yamagami H, Liu M, Steagall RJ, Schirra F, Suzuki T, Krenzer KL, Cermak JM, Sullivan RM, Richards SM, Schaumberg DA, Dana MR, Sullivan BD. Sex steroids, the meibomian gland and evaporative dry eye. Adv Exp Med Biol. 2002; 506(Pt A):389-99. PMID: 12613938.
    View in: PubMed
  262. Sullivan DA, Schaumberg DA, Suzuki T, Schirra F, Liu M, Richards S, Sullivan RM, Dana MR, Sullivan BD. Sex steroids, meibomian gland dysfunction and evaporative dry eye in Sjögren's syndrome. Lupus. 2002; 11(10):667. PMID: 12413064.
    View in: PubMed
  263. Maw R, Pineda R, Pasquale LR, Dana MR. Traumatic ruptured globe injuries in children. Int Ophthalmol Clin. 2002; 42(3):157-65. PMID: 12131592.
    View in: PubMed
  264. Dana MR, Hamrah P. Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye. Adv Exp Med Biol. 2002; 506(Pt B):729-38. PMID: 12613985.
    View in: PubMed
  265. Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol. 2002; 506(Pt B):989-98. PMID: 12614022.
    View in: PubMed
  266. Sullivan RM, Cermak JM, Papas AS, Dana MR, Sullivan DA. Economic and quality of life impact of dry eye symptoms in women with Sjögren's syndrome. Adv Exp Med Biol. 2002; 506(Pt B):1183-8. PMID: 12614049.
    View in: PubMed
  267. Sullivan BD, Cermak JM, Sullivan RM, Papas AS, Evans JE, Dana MR, Sullivan DA. Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sjögren's syndrome. Adv Exp Med Biol. 2002; 506(Pt A):441-7. PMID: 12613944.
    View in: PubMed
  268. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA. 2001 Nov 07; 286(17):2114-9. PMID: 11694152.
    View in: PubMed
  269. Liu Y, Dana MR, Tewari V, Taylor AW. Immune response to intragraft antigen in draining lymph nodes after corneal transplantation is mediated by interleukin-12. J Interferon Cytokine Res. 2001 Oct; 21(10):813-9. PMID: 11710993.
    View in: PubMed
  270. Dana MR, Sullivan DA, Parke AL. Toward optimal health: the experts discuss dry eye syndrome. Interview by Jodi Godfrey Meisler. J Womens Health Gend Based Med. 2001 Oct; 10(8):725-9. PMID: 11703883.
    View in: PubMed
  271. Balaram M, Dana MR. Phacoemulsification in patients after allogeneic bone marrow transplantation. Ophthalmology. 2001 Sep; 108(9):1682-7. PMID: 11535473.
    View in: PubMed
  272. Boisgérault F, Liu Y, Anosova N, Ehrlich E, Dana MR, Benichou G. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation. J Immunol. 2001 Aug 15; 167(4):1891-9. PMID: 11489968.
    View in: PubMed
  273. Qian Y, Dana MR. Molecular mechanisms of immunity in corneal allotransplantation and xenotransplantation. Expert Rev Mol Med. 2001 Jul 16; 3(18):1-21. PMID: 14585142.
    View in: PubMed
  274. Yamagami S, Dana MR. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci. 2001 May; 42(6):1293-8. PMID: 11328742.
    View in: PubMed
  275. Qian Y, Boisgerault F, Benichou G, Dana MR. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. Invest Ophthalmol Vis Sci. 2001 Apr; 42(5):987-94. PMID: 11274076.
    View in: PubMed
  276. Graham MA, Azar NF, Dana MR. Visual rehabilitation in children with congenital hereditary endothelial dystrophy. Int Ophthalmol Clin. 2001; 41(4):9-18. PMID: 11698732.
    View in: PubMed
  277. Balaram M, Schaumberg DA, Dana MR. Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol. 2001 Jan; 131(1):30-6. PMID: 11162976.
    View in: PubMed
  278. Yamada J, Zhu SN, Streilein JW, Dana MR. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation. Invest Ophthalmol Vis Sci. 2000 Dec; 41(13):4203-8. PMID: 11095616.
    View in: PubMed
  279. Qian Y, Dekaris I, Yamagami S, Dana MR. Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants. Arch Ophthalmol. 2000 Dec; 118(12):1666-71. PMID: 11115261.
    View in: PubMed
  280. Krenzer KL, Dana MR, Ullman MD, Cermak JM, Tolls DB, Evans JE, Sullivan DA. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab. 2000 Dec; 85(12):4874-82. PMID: 11134156.
    View in: PubMed
  281. Dana MR, Qian Y, Hamrah P. Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea. 2000 Sep; 19(5):625-43. PMID: 11009315.
    View in: PubMed
  282. Khadem JJ, Dana MR. Photodynamic biologic tissue glue in perforating rabbit corneal wounds. J Clin Laser Med Surg. 2000 Jun; 18(3):125-9. PMID: 11799976.
    View in: PubMed
  283. Zhu SN, Yamada J, Streilein JW, Dana MR. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants. Transplantation. 2000 Mar 15; 69(5):1008-13. PMID: 10755569.
    View in: PubMed
  284. Dekaris IJ, Yamada JJ, Streilein WJ, Dana RM. Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts. Curr Eye Res. 1999 Nov; 19(5):456-9. PMID: 10520223.
    View in: PubMed
  285. Yamagami S, Miyazaki D, Ono SJ, Dana MR. Differential chemokine gene expression in corneal transplant rejection. Invest Ophthalmol Vis Sci. 1999 Nov; 40(12):2892-7. PMID: 10549649.
    View in: PubMed
  286. Keane-Myers AM, Miyazaki D, Liu G, Dekaris I, Ono S, Dana MR. Prevention of allergic eye disease by treatment with IL-1 receptor antagonist. Invest Ophthalmol Vis Sci. 1999 Nov; 40(12):3041-6. PMID: 10549671.
    View in: PubMed
  287. Yamada J, Streilein JW, Dana MR. Role of tumor necrosis factor receptors TNFR-I (P55) and TNFR-II (P75) in corneal transplantation. Transplantation. 1999 Oct 15; 68(7):944-9. PMID: 10532532.
    View in: PubMed
  288. Sullivan DA, Wickham LA, Rocha EM, Krenzer KL, Sullivan BD, Steagall R, Cermak JM, Dana MR, Ullman MD, Sato EH, Gao J, Rocha FJ, Ono M, Silveira LA, Lambert RW, Kelleher RS, Tolls DB, Toda I. Androgens and dry eye in Sjögren's syndrome. Ann N Y Acad Sci. 1999 Jun 22; 876:312-24. PMID: 10415627.
    View in: PubMed
  289. Zhu S, Dekaris I, Duncker G, Dana MR. Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation. J Interferon Cytokine Res. 1999 Jun; 19(6):661-9. PMID: 10433368.
    View in: PubMed
  290. Zhu SN, Dana MR. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. Invest Ophthalmol Vis Sci. 1999 Jun; 40(7):1427-34. PMID: 10359324.
    View in: PubMed
  291. Sullivan DA, Krenzer KL, Sullivan BD, Tolls DB, Toda I, Dana MR. Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency? Invest Ophthalmol Vis Sci. 1999 May; 40(6):1261-5. PMID: 10235562.
    View in: PubMed
  292. Streilein JW, Yamada J, Dana MR, Ksander BR. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant Proc. 1999 May; 31(3):1472-5. PMID: 10330973.
    View in: PubMed
  293. Schaumberg DA, Ridker PM, Glynn RJ, Christen WG, Dana MR, Hennekens CH. High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol. 1999 Apr; 9(3):166-71. PMID: 10192648.
    View in: PubMed
  294. Dekaris I, Zhu SN, Dana MR. TNF-alpha regulates corneal Langerhans cell migration. J Immunol. 1999 Apr 01; 162(7):4235-9. PMID: 10201952.
    View in: PubMed
  295. Schaumberg DA, Moyes AL, Gomes JA, Dana MR. Corneal transplantation in young children with congenital hereditary endothelial dystrophy. Multicenter Pediatric Keratoplasty Study. Am J Ophthalmol. 1999 Apr; 127(4):373-8. PMID: 10218688.
    View in: PubMed
  296. Goslings WR, Yamada J, Dana MR, Streilein JW, van Beelen E, Prodeus AP, Carroll MC, Jager MJ. Corneal transplantation in antibody-deficient hosts. Invest Ophthalmol Vis Sci. 1999 Jan; 40(1):250-3. PMID: 9888452.
    View in: PubMed
  297. Yamada J, Dana MR, Zhu SN, Alard P, Streilein JW. Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch Ophthalmol. 1998 Oct; 116(10):1351-7. PMID: 9790635.
    View in: PubMed
  298. Dana MR, Zhu SN, Yamada J. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea. 1998 Jul; 17(4):403-9. PMID: 9676913.
    View in: PubMed
  299. Sullivan DA, Rocha EM, Ullman MD, Krenzer KL, Gao J, Toda I, Dana MR, Bazzinotti D, da Silveira LA, Wickham LA. Androgen regulation of the meibomian gland. Adv Exp Med Biol. 1998; 438:327-31. PMID: 9634904.
    View in: PubMed
  300. Schaumberg DA, Snow KK, Dana MR. The epidemic of Acanthamoeba keratitis: where do we stand? Cornea. 1998 Jan; 17(1):3-10. PMID: 9436873.
    View in: PubMed
  301. Dana MR, Dai R, Zhu S, Yamada J, Streilein JW. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege. Invest Ophthalmol Vis Sci. 1998 Jan; 39(1):70-7. PMID: 9430547.
    View in: PubMed
  302. Streilein JW, Dana MR, Ksander BR. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today. 1997 Sep; 18(9):443-9. PMID: 9293161.
    View in: PubMed
  303. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation. 1997 May 27; 63(10):1501-7. PMID: 9175817.
    View in: PubMed
  304. Goren MB, Dana MR, Rapuano CJ, Gomes JA, Cohen EJ, Laibson PR. Corneal topography after selective suture removal for astigmatism following keratoplasty. Ophthalmic Surg Lasers. 1997 Mar; 28(3):208-14. PMID: 9076794.
    View in: PubMed
  305. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997 Feb; 104(2):236-44. PMID: 9052627.
    View in: PubMed
  306. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology. 1996 Nov; 103(11):1846-53. PMID: 8942880.
    View in: PubMed
  307. Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci. 1996 Nov; 37(12):2485-94. PMID: 8933765.
    View in: PubMed
  308. Dana MR, Schaumberg DA, Moyes AL, Gomes JA, Laibson PR, Holland EJ, Sugar A, Sugar J. Outcome of penetrating keratoplasty after ocular trauma in children. Arch Ophthalmol. 1995 Dec; 113(12):1503-7. PMID: 7487616.
    View in: PubMed
  309. Dana MR, Schaumberg DA, Kowal VO, Goren MB, Rapuano CJ, Laibson PR, Cohen EJ. Corneal neovascularization after penetrating keratoplasty. Cornea. 1995 Nov; 14(6):604-9. PMID: 8575183.
    View in: PubMed
  310. Gomes JA, Dana MR, Dua HS, Goren MB, Laibson PR, Cohen EJ. Positive donor rim culture in penetrating keratoplasty. Cornea. 1995 Sep; 14(5):457-62. PMID: 8536457.
    View in: PubMed
  311. Dana MR, Moyes AL, Gomes JA, Rosheim KM, Schaumberg DA, Laibson PR, Holland EJ, Sugar A, Sugar J. The indications for and outcome in pediatric keratoplasty. A multicenter study. Ophthalmology. 1995 Aug; 102(8):1129-38. PMID: 9097737.
    View in: PubMed
  312. Dana MR, Goren MB, Gomes JA, Laibson PR, Rapuano CJ, Cohen EJ. Suture erosion after penetrating keratoplasty. Cornea. 1995 May; 14(3):243-8. PMID: 7600806.
    View in: PubMed
  313. Werner MS, Dana MR, Viana MA, Shapiro M. Predictors of occult scleral rupture. Ophthalmology. 1994 Dec; 101(12):1941-4. PMID: 7997332.
    View in: PubMed
  314. Dana MR, Viana MA, Mori MT, Chandler JW, McMahon TT. Dynamic shifts in corneal topography after radial and transverse keratotomy. Ophthalmology. 1994 Nov; 101(11):1818-26. PMID: 7800363.
    View in: PubMed
  315. Dana MR, Hochman MA, Viana MA, Hill CH, Sugar J. Ocular manifestations of leprosy in a noninstitutionalized community in the United States. Arch Ophthalmol. 1994 May; 112(5):626-9. PMID: 8185519.
    View in: PubMed
  316. Dana MR, Mori MT, Chandler JW, McMahon TT. Artificial orbit for experimental surgery on the anterior segment. Arch Ophthalmol. 1994 Jan; 112(1):125-8. PMID: 8285880.
    View in: PubMed
  317. Dana MR, Werner MS, Viana MA, Shapiro MJ. Spontaneous and traumatic vitreous hemorrhage. Ophthalmology. 1993 Sep; 100(9):1377-83. PMID: 8371927.
    View in: PubMed
  318. Dana MR, Putz JL, Viana MA, Sugar J, McMahon TT. Contact lens failure in keratoconus management. Ophthalmology. 1992 Aug; 99(8):1187-92. PMID: 1513569.
    View in: PubMed
  319. Dana MR, Tielsch JM, Enger C, Joyce E, Santoli JM, Taylor HR. Visual impairment in a rural Appalachian community. Prevalence and causes. JAMA. 1990 Nov 14; 264(18):2400-5. PMID: 2231996.
    View in: PubMed
  320. Dana MR, Olkowski ST, Ahmadian H, Stark WJ, Young EM. Low-dose ultraviolet-B irradiation of donor corneal endothelium and graft survival. Invest Ophthalmol Vis Sci. 1990 Nov; 31(11):2261-8. PMID: 2242992.
    View in: PubMed
  321. Young E, Olkowski ST, Dana M, Mallette RA, Stark WJ. Pretreatment of donor corneal endothelium with ultraviolet-B irradiation. Transplant Proc. 1989 Feb; 21(1 Pt 3):3145-6. PMID: 2468253.
    View in: PubMed
  322. Willcockson JC, Bolton B, Dana RH. A comparison of six MMPI short forms: code type correspondence and indices of psychopathology. J Clin Psychol. 1983 Nov; 39(6):968-9. PMID: 6662952.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Dana's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (824)
Explore
_
Co-Authors (65)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_